Michael L. Cher

Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.

Michael L. Cher, G. Steven Bova, David H. Moore et al. · PubMed · 1996 · 395 citations

Life Sciences, Genetics, Oncology +13

CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: The role of bone microenvironment‐associated CXCL12

Sreenivasa R. Chinni, Sivasakthy Sivalogan, Zhong Dong et al. · The Prostate · 2005 · 246 citations

Medicine, Cancer Biology, Oncology +17

Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy.

Michael L. Cher, Fernando J. Bianco, J. Lam et al. · PubMed · 1998 · 228 citations

Medicine, Nuclear Medicine, Urology +16

Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.

Jeffrey A. Nemeth, John F. Harb, Ubirajara Barroso et al. · PubMed · 1999 · 219 citations

Medicine, Cell Biology, Oncology +17

Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM

Dejuan Kong, Elisabeth I. Heath, Wei Chen et al. · PLoS ONE · 2012 · 215 citations · Full text

Medicine, Molecular Biology, Oncology +17